Scholarlink

<p>Cardiovascular diseases remain one of the leading causes of mortality among adults worldwide, with elevated blood lipid levels serving as a key modifiable risk factor. This study aimed to investigate the probiotic potential of lactic acid bacteria (LAB) isolated from ginseng sprouts (<i>Panax ginseng</i> Meyer) cultivated under smart-farming conditions, with a particular emphasis on their cholesterol-lowering properties. Out of 485 isolates, five strains of <i>Lacticaseibacillus rhamnosus</i> were selected based on superior in vitro performance and identified through 16&#xa0;S rRNA sequencing and phylogenetic analysis. The selected strains demonstrated high tolerance to simulated gastrointestinal conditions (pH 3.0, 0.3% bile salts), with survival rates ranging from 98 to 99%. In addition, they exhibited robust antibacterial activity, notable antioxidant capacity and antibiotic susceptibility to erythromycin and clindamycin, while showed resistance to tetracycline and vancomycin. The selected bacterial strains reduced cholesterol levels by 30% as compared to the reference strain <i>Lacticaseibacillus rhamnosus</i> GG. Moreover, the formation of white precipitates around the bacterial colonies grown on media supplemented with 0.5% (w/v) TDCA and 0.37&#xa0;g/L CaCl<sub>2</sub> indicated elevated bile salt hydrolase (BSH) activity, corroborated by increased taurine release (15&#xa0;mg/mL). Collectively, these findings highlight the safety and functional efficacy of the selected <i>L. rhamnosus</i> strains, supporting their potential application in cholesterol management as next-generation probiotics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Probiotic potential of ginseng derived Lacticaseibacillus rhamnosus strains with hypocholesterolemic, antioxidant and antibacterial activities

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月9日

查看全文
  • Enam Ahmed,
  • Ji-Eun Lee,
  • Muhammad Hamayun,
  • Selin Jung,
  • Ho-Youn Kim,
  • Bokyung Lee

摘要

Cardiovascular diseases remain one of the leading causes of mortality among adults worldwide, with elevated blood lipid levels serving as a key modifiable risk factor. This study aimed to investigate the probiotic potential of lactic acid bacteria (LAB) isolated from ginseng sprouts (Panax ginseng Meyer) cultivated under smart-farming conditions, with a particular emphasis on their cholesterol-lowering properties. Out of 485 isolates, five strains of Lacticaseibacillus rhamnosus were selected based on superior in vitro performance and identified through 16 S rRNA sequencing and phylogenetic analysis. The selected strains demonstrated high tolerance to simulated gastrointestinal conditions (pH 3.0, 0.3% bile salts), with survival rates ranging from 98 to 99%. In addition, they exhibited robust antibacterial activity, notable antioxidant capacity and antibiotic susceptibility to erythromycin and clindamycin, while showed resistance to tetracycline and vancomycin. The selected bacterial strains reduced cholesterol levels by 30% as compared to the reference strain Lacticaseibacillus rhamnosus GG. Moreover, the formation of white precipitates around the bacterial colonies grown on media supplemented with 0.5% (w/v) TDCA and 0.37 g/L CaCl2 indicated elevated bile salt hydrolase (BSH) activity, corroborated by increased taurine release (15 mg/mL). Collectively, these findings highlight the safety and functional efficacy of the selected L. rhamnosus strains, supporting their potential application in cholesterol management as next-generation probiotics.